Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
According to Medtronic's latest financial reports and stock price the company's current Operating Margin is 17.17%. At the end of 2023 the company had an Operating Margin of 17.18%.
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.